The impact of long-term changes in metabolic status on cardiovascular biomarkers and microvascular endothelial function in middle-aged men: A 25-year prospective study

Diabetology and Metabolic Syndrome

Volumn 7, Issue 1, 2015, Pages

  Kwas̈niewska, Magdalena ^a   Kozińska, Joanna ^a   Dziankowska Zaborszczyk, Elzbieta ^a   Kostka, Tomasz ^a   Jegier, Anna ^a   Rębowska, Ewa ^a   Orczykowska, Milena ^b   Leszczyńska, Joanna ^a   Drygas, Wojciech ^a,c  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Maria Konopnicka Paediatric Centre   (Poland)

^c INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Biomarkers; Disorders; Endothelial; Metabolic syndrome; Physical activity; Reactive hyperemia

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LEPTIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; BODY MASS; CAPILLARY ENDOTHELIAL CELL; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL FUNCTION; COHORT ANALYSIS; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH STATUS; HUMAN; HUMAN EXPERIMENT; LIFESTYLE; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; NORMAL HUMAN; PHYSICAL ACTIVITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REACTIVE HYPEREMIA INDEX; RISK ASSESSMENT; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 84941800578     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/s13098-015-0074-8     Document Type: Article

References (59)

1. Grundy SM. Pre-diabetes, metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol. 2012;59:635-43. doi: 10.1016/j.jacc.2011.08.080.
2. Czernichow S, Greenfield Galan P, et al. Macrovascular and microvascular dysfunction in the metabolic syndrome. Hypertens Res. 2010;33:293-7.
3. Vanhoutte PM, Shimokawa H, Tang H, Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol (Oxf). 2009;196:193-222.
4. Nishida M, Moriyama T, Ishii K, Takashima S, Yoshizaki K, Sugita Y, Yamauchi-Takihara K. Effects of IL-6, adiponectin, CRP and metabolic syndrome on subclinical atherosclerosis. Clin Chim Acta. 2007;384:99-104.
5. Yan E, Chen S, Hong K, Kim WS, Bajpai A, Treyzon L, et al. Insulin, hs-CRP, leptin, and adiponectin. An analysis of their relationship to the metabolic syndrome in an obese population with an elevated waist circumference. Metab Syndr Relat Disord. 2008;6:64-73. doi: 10.1089/met.2007.0027.
6. Oda E, Kawai R. Comparison between high-sensitivity C-reactive protein (hs-CRP) and white blood cell count (WBC) as an inflammatory component of metabolic syndrome in Japanese. Intern Med. 2010;49:117-24.
7. Esper RJ, Nordaby RA, Vilariño JO, Paragano A, Cacharrón JL, Machado RA. Endothelial dysfunction: a comprehensive appraisal. Cardiovasc Diabetol. 2006;235:4.
8. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007;115:1285-95.
9. Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation. 2005;111:363-8.
10. Laaksonen DE, Lakka HM, Salonen JT, Niskanen LK, Rauramaa R, Lakka TA. Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care. 2002;25:1612-8.
11. Huang Y, Liu X. Leisure-time physical activity and the risk of metabolic syndrome: meta-analysis. Eur J Med Res. 2014;19:22. doi: 10.1186/2047-783X-19-22.
12. Kwas̈niewska M, Jegier A, Kostka T, Dziankowska-Zaborszczyk E, Rębowska E, Kozińska J, Drygas W. Long-term effect of different physical activity levels on subclinical atherosclerosis in middle-aged men: a 25-year prospective study. PLoS One. 2014;9:e85209. doi: 10.1371/journal.pone.0085209.
13. Katano S, Nakamura Y, Okuda N, Murakami Y, Chiba N, Yoshita K, Tanaka T, Tamaki J, Takebayashi T, Okayama A, Miura K, Okamura T, Ueshima H, HIPOP-OHP Research Group. Relationship between dietary and other lifestyle habits and cardiometabolic risk factors in men. Diabetol Metab Syndr. 2011;3:30. doi: 10.1186/1758-5996-3-30.
14. Hamdy O, Ledbury S, Mullooly C, Jarema C, Porter S, Ovalle K, et al. Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care. 2003;26:2119-25.
15. Mora S, Cook N, Buring JE, Ridker PM, Lee IM. Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation. 2007;116:2110-8.
16. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, et al. National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110(2):227-39.
17. Fox SM 3rd, Naughton JP, Gorman PA. Physical activity and cardiovascular health. 3. The exercise prescription: frequency and type of activity. Mod Concepts Cardiovasc Dis. 1972;41(6):25-30.
18. Kriska AM, Caspersen CJ. Historical leisure activity questionnaire: a collection of physical activity questionnaires for health-related research. Med Sci Sports Exerc. 1997;29:S43-9.
19. Gore C, Booth ML, Bauman A, Owen N. Utility of pwc75% as an estimate of aerobic power in epidemiological and population-based studies. Med Sci Sports Exerc. 1999;31:348-51.
20. Rubinshtein R, Kuvin JT, Soffler M, Lennon RJ, Lavi S, Nelson RE, et al. Assessment of endothelial function by non-invasive peripheral tonometry predicts late cardiovascular adverse events. Eur Heart J. 2010;31:1142-8.
21. Gupta AK, Johnson WD. Prediabetes and prehypertension in disease free obese adults correlate with an exacerbated systemic proinflammatory milieu. J Inflamm. 2010;7:36. doi: 10.1186/1476-9255-7-36.
22. Gupta AK, McGlone M, Greenway FL, Johnson WD. Prehypertension in disease-free adults: a marker for an adverse cardiometabolic risk profile. Hypertens Res. 2010;33:905-10. doi: 10.1038/hr.2010.91.
23. Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation. 2003;111:363-8.
24. Li J, Flammer AJ, Lennon RJ, Nelson RE, Gulati R, Friedman PA, et al. Comparison of the effect of the metabolic syndrome and multiple traditional cardiovascular risk factors on vascular function. Mayo Clin Proc. 2012;87:968-75. doi: 10.1016/j.mayocp.2012.07.004.
25. Gupta AK, Ravussin E, Johannsen DL, Stull AJ, Cefalu WT, Johnson WD. Endothelial dysfunction: an early cardiovascular risk marker in asymptomatic obese individuals with prediabetes. Br J Med Med Res. 2012;2:413-23.
26. Gupta AK, Johnson WD, Johannsen D, Ravussin E. Cardiovascular risk escalation with caloric excess: a prospective demonstration of the mechanics in healthy adults. Cardiovasc Diabetol. 2013;12:23. doi: 10.1186/1475-2840-12-23.
27. Hamburg NM, Larson MG, Vita JA, Vasan RS, Keyes MJ, Widlansky ME, et al. Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in Framingham Offspring participants without clinical evidence of cardiovascular disease. Am J Cardiol. 2008;101:82-8.
28. Toggweiler S, Schoenenberger A, Urbanek N, Erne P. The prevalence of endothelial dysfunction in patients with and without coronary artery disease. Clin Cardiol. 2010;33:746-52. doi: 10.1002/clc.20836.
29. Konttinen J, Lindholm H, Sinisalo J, Kuosma E, Halonen J, Hopsu L, Uitti J. Association between lowered endothelial function measured by peripheral arterial tonometry and cardio-metabolic risk factors - a cross-sectional study of Finnish municipal workers at risk of diabetes and cardiovascular disease. BMC Cardiovasc Disord. 2013;13:83. doi: 10.1186/1471-2261-13-83.
30. Carnovale V, Paradis ME, Gigleux I, Ramprasath VR, Couture P, Jones PJ, et al. Correlates of reactive hyperemic index in men and postmenopausal women. Vasc Med. 2013;18:340-6. doi: 10.1177/1358863X13507975.
31. Eckel RH, Alberti KG, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2010;375:181-3. doi: 10.1016/S0140-6736(09)61794-3.
32. Peterson MD, Al Snih S, Serra-Rexach JA, Burant C. Android adiposity and lack of moderate and vigorous physical activity are associated with insulin resistance and diabetes in aging adults. J Gerontol A Biol Sci Med Sci. 2015;70(8):1009-17. doi: 10.1093/gerona/glv002.
33. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135-43.
34. Trepels T, Zeiher AM, Fichtlscherer S. The endothelium and inflammation. Endothelium. 2006;13:423-9.
35. Devaraj S, Singh U, Jialal I. Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol. 2009;20:182-9. doi: 10.1097/MOL.0b013e32832ac03e.
36. Vu JD, Vu JB, Pio JR, Malik S, Franklin SS, Chen RS, Wong ND. Impact of C-reactive protein on the likelihood of peripheral arterial disease in United States adults with the metabolic syndrome, diabetes mellitus, and preexisting cardiovascular disease. Am J Cardiol. 2005;96:655-8.
37. Stibůrková B, Pavlíková M, Sokolová J, Kožich V. Metabolic syndrome, alcohol consumption and genetic factors are associated with serum uric acid concentration. PLoS One. 2014;9:e97646. doi: 10.1371/journal.pone.0097646.
38. Lee YJ, Cho S, Kim SR. A possible role of serum uric acid as a marker of metabolic syndrome. Intern Med J. 2014;44:1210-6. doi: 10.1111/imj.12588.
39. Erdogan D, Gullu H, Caliskan M, Yildirim E, Bilgi M, Ulus T, et al. Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults. Int J Clin Pract. 2005;59:1276-82.
40. Grundy SM. Adipose tissue and metabolic syndrome: too much, too little, or neither. Eur J Clin Invest. 2015;. doi: 10.1111/eci.12519.
41. Glass CK, Olefsky JM. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 2012;15(5):635-45. doi: 10.1016/j.cmet.2012.04.001.
42. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334:292-5.
43. Leyva F, Godsland IF, Ghatei M, Proudler AJ, Aldis S, Walton C, et al. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol. 1998;18(6):928-33.
44. Lopes HF, Klein RL, Garvey WT, Goodfriend T, Egan BM. Influence of acute hyperlipidemia to adipocyte-derived hormones in lean normotensive and subjects with metabolic syndrome. Diabetol Metab Syndr. 2014;6(1):132. doi: 10.1186/1758-5996-6-132.
45. Li WC, Hsiao KY, Chen IC, Chang YC, Wang SH, Wu KH. Serum leptin is associated with cardiometabolic risk and predicts metabolic syndrome in Taiwanese adults. Cardiovasc Diabetol. 2011;10:36. doi: 10.1186/1475-2840-10-36.
46. Galletti F, Barbato A, Versiero M, Iacone R, Russo O, Barba G, et al. Circulating leptin levels predict the development of metabolic syndrome in middle-aged men: an 8-year follow-up study. J Hypertens. 2007;25(8):1671-7.
47. Baden MY, Yamada Y, Obata Y, Hosakawa Y, Saisho K, Tamba S, et al. Serum adiponectin level is not only decreased in metabolic syndrome but also in borderline metabolic abnormalities. Nutr Diabetes. 2011;1:e18. doi: 10.1038/nutd.2011.13.
48. Vega GL, Grundy SM. Metabolic risk susceptibility in men is partially related to adiponectin/leptin ratio. J Obes. 2013;2013:409679. doi: 10.1155/2013/409679.
49. Chen JQ, Huang YY, Gusdon AM, Qu S. Irisin: a new molecular marker and target in metabolic disorder. Lipids Health Dis. 2015;14:2. doi: 10.1186/1476-511X-14-2.
50. Huh JY, Siopi A, Mougios V, Park KH, Mantzoros CS. Irisin in response to exercise in humans with and without metabolic syndrome. J Clin Endocrinol Metab. 2015;100:E453-7. doi: 10.1210/jc.2014-2416.
51. Hou N, Han F, Sun X. The relationship between circulating irisin levels and endothelial function in lean and obese subjects. Clin Endocrinol (Oxf). 2014;. doi: 10.1111/cen.12658.
52. Esteve E, Castro A, López-Bermejo A, Vendrell J, Ricart W, Fernández-Real JM. Serum interleukin-6 correlates with endothelial dysfunction in healthy men independently of insulin sensitivity. Diabetes Care. 2007;30:939-45.
53. Vita JA, Keaney JF Jr, Larson MG, Keyes MJ, Massaro JM, Lipinska I, et al. Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study. Circulation. 2004;110:3604-9.
54. Weiner SD, Ahmed HN, Jin Z, Cushman M, Herrington DM, Nelson JC, et al. Systemic inflammation and brachial artery endothelial function in the Multi-Ethnic Study of Atherosclerosis (MESA). Heart. 2014;100:862-6.
55. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301-14.
56. Hartman J, Frishman WH. Inflammation and atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy. Cardiol Rev. 2014;22:147-51. doi: 10.1097/CRD.0000000000000021.
57. Hallmark R, Patrie JT, Liu Z, Gaesser GA, Barrett EJ, Weltman A. The effect of exercise intensity on endothelial function in physically inactive lean and obese adults. PLoS One. 2014;9(1):e85450. doi: 10.1371/journal.pone.0085450.
58. Kirma C, Akcakoyun M, Esen AM, Barutcu I, Karakaya O, Saglam M, et al. Relationship between endothelial function and coronary risk factors in patients with stable coronary artery disease. Circ J. 2007;71(5):698-702.
59. Sauder KA, West SG, McCrea CE, Campbell JM, Jenkins AL, Jenkins DJ, Kendall CW. Test-retest reliability of peripheral arterial tonometry in the metabolic syndrome. Diab Vasc Dis Res. 2014;11:201-7. doi: 10.1177/1479164114525971.